N-(2-(m-tolyl)-4,6-dihydro-2H-thieno[3,4-c]pyrazol-3-yl)cyclopropanecarboxamide结构式
|
常用名 | N-(2-(m-tolyl)-4,6-dihydro-2H-thieno[3,4-c]pyrazol-3-yl)cyclopropanecarboxamide | 英文名 | N-(2-(m-tolyl)-4,6-dihydro-2H-thieno[3,4-c]pyrazol-3-yl)cyclopropanecarboxamide |
|---|---|---|---|---|
| CAS号 | 392289-10-0 | 分子量 | 299.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C16H17N3OS | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(2-(m-tolyl)-4,6-dihydro-2H-thieno[3,4-c]pyrazol-3-yl)cyclopropanecarboxamide |
|---|
| 分子式 | C16H17N3OS |
|---|---|
| 分子量 | 299.4 |
| InChIKey | LHWGKDXHRHVYLH-UHFFFAOYSA-N |
| SMILES | CC1=CC(=CC=C1)N2C(=C3CSCC3=N2)NC(=O)C4CC4 |
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|